Biotechnology

Filter

Current filters:

None

Popular Filters

62 to 86 of 2508 results

European Commission approves added indication for Janssen’s Velcade, in MCL

European Commission approves added indication for Janssen’s Velcade, in MCL

06-02-2015

US health care giant Johnson & Johnson (NYSE: JNJ) subsidiary Janssen-Cilag International NV (Janssen)…

BiotechnologyEuropeJanssen-Cilag InternationalJohnson & JohnsonOncologyRegulationVelcade

Nano-carrier drugs for pancreatic cancer now being produced In China

06-02-2015

At the Symposium on the Application of Genetic Testing in Individualized Diagnosis and Treatment of Tumor…

BiotechnologyChinaOncologyResearch

Genticel licenses Vaxiclase platform to Serum Institute of India

04-02-2015

French biotech firm Genticel, a developer of therapeutic vaccines, has licensed its Vaxiclase technology…

BiotechnologyGenticelSerum Institute of IndiaVaxiclase

Gilead beats 4th-qtr 2014 expectations, as hepatitis C drug sales soar

Gilead beats 4th-qtr 2014 expectations, as hepatitis C drug sales soar

04-02-2015

US biotech firm Gilead Sciences posted fourth-quarter and full-year financial results after markets closed…

Anti-viralsBiotechnologyFinancialGilead SciencesHarvoniSovaldi

Pfizer abandons deal with Repligen on SMA drug candidate

Pfizer abandons deal with Repligen on SMA drug candidate

03-02-2015

US biologics specialist Repligen revealed in a filing with the Securities and Exchange Commission that…

BiotechnologyLicensingNeurologicalPfizerRepligenRG3039

New biotech start-up OptiKira created by BioMotiv

New biotech start-up OptiKira created by BioMotiv

02-02-2015

USA-based BioMotiv, a drug development accelerator associated with The Harrington Project, the University…

BioMotivBiotechnologyDiabetesMergers & AcquisitionsOptiKiraRare diseasesResearch

Chimerix to drop development of brincidofovir for Ebola

Chimerix to drop development of brincidofovir for Ebola

02-02-2015

US antiviral biopharma company Chimerix says that, after discussion with the US Food and Drug Administration,…

Anti-viralsBiotechnologybrincidofovirChimerixResearchTropical diseasesUSA

NicOx in-licenses AzaSite and BromSite from InSite Vision

NicOx in-licenses AzaSite and BromSite from InSite Vision

02-02-2015

Ophthalmology-focused French biotech firm NicOx has signed a license agreement with USA-based InSite…

AzaSiteBiotechnologyBromSiteEuropeInSite VisionLicensingNicOxOphthalmicsRest of the World

Motif Bio to list on AIM to progress novel antibiotic

Motif Bio to list on AIM to progress novel antibiotic

02-02-2015

Motif Bio has announced its intention to list on the alternative Investment Market to raise at least…

Antibiotics and Infectious diseasesBiotechnologyFinancialMotif BiosciencesUK

Biogen Idec 2014 revenues and earnings rocket

30-01-2015

US biotech major Biogen Idec yesterday reported full-year and fourth quarter 2014 results, showing that…

Biogen IdecBiotechnologyFinancial

Valeant to serve as “stalking horse bidder” in court-supervised Dendreon sales process

30-01-2015

US biotech firm Dendreon says it has reached an agreement with Canada’s Valeant Pharmaceuticals International…

BiotechnologyDendreonMergers & AcquisitionsOncologyProvengeValeant Pharmaceuticals International

CMOs must offer meaningful value to take advantage of biosimilars trend, says report

30-01-2015

If contract manufacturing organizations are to take advantage of the wave of interest in biosimilars,…

BiosimilarsBiotechnologyComputer hardwareLicensingPharmSourceProduction

Strong cancer drug sales boost Celgene 4th-qtr and full-year 2014 results

Strong cancer drug sales boost Celgene 4th-qtr and full-year 2014 results

29-01-2015

US biotech firm Celgene posted 2014 financials before the markets opened this morning, showing that fourth…

AbraxaneBiotechnologyCelgene CorpFinancialOncologyRevlimid

Australia: Foresight to translate research into treatments, devices and diagnostics

29-01-2015

Amid the growing realization that Australian research needs support to make it a reality, the Queensland…

AustraliaBiotechnologyFinancialResearch

AstraZeneca to employ CRISPR, a new technique for drug discovery

AstraZeneca to employ CRISPR, a new technique for drug discovery

29-01-2015

Anglo-Swedish pharma major AstraZeneca has announced a research program to develop new medicines that…

AstraZenecaBiologyBiotechnologyResearchUK

Study shows Photocure's Hexvix significantly improves overall survival in bladder cancer

Study shows Photocure's Hexvix significantly improves overall survival in bladder cancer

29-01-2015

Photodynamic technology specialist Photocure has published data on a retrospective study showing Hexvix…

BiotechnologyHexvixOncologyPhotocureResearch

Valneva grants license to Immune Targeting Systems for the development of hepatitis B vaccine

Valneva grants license to Immune Targeting Systems for the development of hepatitis B vaccine

29-01-2015

France-based biotech firm Valneva and UK company Immune Targeting Systems (ITS) have signed an exclusive…

Anti-viralsBiotechnologyGlobalImmune Targeting SystemsLicensingValneva

RegeneRx links with G-treeBNT to develop RGN-259 in the USA

RegeneRx links with G-treeBNT to develop RGN-259 in the USA

29-01-2015

US biotech firm RegeneRx Biopharmaceuticals has entered into agreements with South Korea-based G-treeBNT…

BiotechnologyG-treeBNTLicensingMergers & AcquisitionsOphthalmicsRegeneRxRGN-259USA

TxCell receives latest 1 million-euro milestone payment in OvaSave license agreement

TxCell receives latest 1 million-euro milestone payment in OvaSave license agreement

29-01-2015

French biotech company TxCell has received the latest 1 million-euro milestone payment ($1.13 million)…

BiotechnologyGastro-intestinalsLicensingOvaSaveResearchTxCell

Gilead promotes Andrew Cheng and Taiyin Yeng to senior leadership

Gilead promotes Andrew Cheng and Taiyin Yeng to senior leadership

29-01-2015

US biotech major Gilead Sciences has promoted Andrew Cheng to executive vice president of HIV therapeutics…

Andrew ChengBiotechnologyBoardroomChemistryGilead SciencesHIVTaiyin YengUSA

AnaMar to focus on severe inflammation and fibrosis

28-01-2015

Swedish privately-held biopharma company AnaMar says it will focus pipeline development on severe inflammation…

AnaMarBiotechnologyInflammatory diseasesLicensingResearchRespiratory and Pulmonary

Dendreon extends deadline for qualified bids for the company

Dendreon extends deadline for qualified bids for the company

28-01-2015

US biotech firm Dendreon said yesterday that it would be extending the bid deadline for interested parties…

BiotechnologyDendreonMergers & AcquisitionsOncologyProvenge

Amgen’s 4th-qtr 2014 earnings and sales beat expectations

Amgen’s 4th-qtr 2014 earnings and sales beat expectations

28-01-2015

US biotech major Amgen reported financial results after markets closed yesterday, revealing that fourth-quarter…

AmgenBiotechnologyFinancialUSA

62 to 86 of 2508 results

COMPANY SPOTLIGHT

Menarini

Back to top